Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Erik Norström

Executive Vice President
Head of Corporate Development

1973, Swedish and Swiss citizen
Member since joining Tecan in 2017

Acquisitions remain an important contributor to our overall growth and a key element of our corporate strategy.

Erik Norström, Executive Vice President, Head of Corporate Development

Erik joined Tecan in December 2017 as Head of Corporate Development and a member of the Management Board.

Before that, he held a number of Corporate Development and M&A positions with increasing management responsibility in the broader healthcare and medical technology industries. From 2015-2017, Erik served as Corporate Vice President, Business Development and a member of the Corporate Leadership Team at Chr. Hansen Holding A/S, Denmark. From 2012 to 2015, Erik Norström was Head of Business Development and M&A at Nobel Biocare AG, Zürich, where he was responsible for the full range of business development and M&A activities, including corporate strategy. Prior to this, he was Head of M&A and Alliances at Nobel Biocare AG, Zürich (2008-2012), and from 2001-2008, he served as Corporate Development Director at F. Hoffmann-La Roche AG, Basel.

Erik holds a Master degree in Chemical Engineering (Chalmers University of Technology, Göteborg, Sweden) and a Bachelor degree in Business Administration with a specialization in Financial Management (Göteborg University of Economics, Sweden).

Professional background (most recent positions)

2015 - 2017

Corporate Vice President strategic development and M&A Member of the Corporate Leadership team at chr. Hansen a/s, Copenhagen, Denmark.

2012 - 2015

Head of Corporate Development and M&A

Member of the Corporate Leadership Team at Nobel Biocare AG, Zürich

2008 - 2012

Head of M&A and alliances at Nobel Biocare AG, Zürich

2001 - 2008

Corporate Development Director at F. Hoffmann-La Roche AG, Basel

1999 - 2001

Capex Analyst at F. Hoffmann-La Roche AG, Basel